The effect of lifestyle-adjustments prior to medical treatment on the effect of medical treatment in reflux patients
Study identifier:N11
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
-
Medical condition
GERD
Phase
-
Healthy volunteers
No
Study drug
esomeprazole
Sex
All
Actual Enrollment
990
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Jun 2004
Primary Completion Date: -
Study Completion Date: 01 Mar 2008
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
A Sellink
AstraZeneca
